Coronavirus This is what is known about inoculation boost
UAn influential federal advisory panel overwhelmingly rejected a plan on Friday to give Pfizer booster vaccines against COVID-19 to most Americans, but I do endorse additional injections for those 65 or older, or those at risk of developing a severe condition.
The two votes were a serious blow to the initiative of the government of President Joe Biden to strengthen the protection of almost all Americans against the contagious delta variant.
The decision was made by a committee of external experts who advise the Food and Drug Administration (FDA).
In a surprising move The panel first rejected, by 16 votes in favor and 2 against, the application of reinforcements for almost everyone. Members noted the lack of data on the safety of additional doses and also raised questions about the value of massive boosters, rather than those targeted to specific groups.
Then, in a vote of 18 in favor and 0 against, endorsed the additional doses for certain sectors of the United States population, specifically the people who are most at risk from the virus.
This will help save part of the White House campaign, but it will remain a big step back from the huge plan proposed by the government a month ago to offer booster vaccines from both Pfizer and Moderna almost all Americans eight months after receiving their second dose.
The vote on Friday was only the first step. The FDA itself is expected to make a decision on boosters in the coming days, although it usually follows the recommendations of the committee.
The offer of reinforcements is also subject to the approval of the Centers for Disease Control and Prevention (CDC). An advisory panel from this body is expected to take up the issue on Wednesday. The CDC has said it is weighing reinforcement for the elderly, nursing home residents and frontline health workers, rather than all adults.
Separate decisions from the FDA and CDC will be required for people who received the vaccines from Moderna or Johnson & Johnson can receive boosters.
During several hours of vigorous debate on Friday, panel members questioned the value of offering reinforcements to almost everyone over the age of 16.
“I don’t think a booster dose is going to contribute significantly to controlling the pandemic,” said Dr. Cody Meissner of Tufts University. “And I think it’s important that the main message we get across is that we have to give everyone two doses.”
CDC’s Dr. Amanda Cohn said: “Right now it is clear that the unvaccinated are driving transmission in the United States.”
– .